RxDoctor Payments Data

Alexander Carrese, DO

Pain Medicine · Middlebury, CTNPI 1437684008

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 70 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by AbbVie at 47.1% of the total. That places this record below the midpoint for pain medicine clinicians in CT, where the typical reported total is $2,061.

$2,007in general payments, 2019–2025

Across 70 payments — averaging $28.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$945
  • SPR Therapeutics, Inc$204
  • Boston Scientific$160
  • Scilex Pharmaceuticals Inc.$133
  • Bioventus LLC$126
  • Regeneron Healthcare Solutions, Inc.$73
  • plus $366 from 12 others

What the payments were for

  • Food & beverage$2,007100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,007 in reported general payments places this provider in the 45th percentile of 69 pain medicine providers in Connecticut.

See all pain medicine providers in Connecticut

Medicare billing

Part B allowed, 2024
$107,512
Medicare patients
203
Services billed
1,426

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Buprenorphine11$3,119
Lidocaine11$1,141
Gabapentin80$968
Oxycodone Hcl104$949
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen69$881
Tramadol Hcl111$628
Pregabalin40$499
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen15$395
Tizanidine Hcl34$330
Cyclobenzaprine Hcl31$308
Celecoxib18$235
Nortriptyline Hcl20$228
Ibuprofen16$176
Naproxen18$172
Baclofen12$127

Paid to pharmacies, not to this prescriber.

Other pain medicine in Middlebury

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →